English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy Journal article
Zhou, Jing, Feng, Ji, Wu, Yong, Dai, Hui Qi, Zhu, Guang Zhi, Chen, Pan Hong, Wang, Li Ming, Lu, Guang, Liao, Xi Wen, Lu, Pei Zhi, Su, Wen Jing, Hooi, Shing Chuan, Ye, Xin Pin, Shen, Han Ming, Peng, Tao, Lu, Guo Dong. Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy[J]. Experimental and Molecular Medicine, 2022, 54(11), 2007-2021.
Authors:  Zhou, Jing;  Feng, Ji;  Wu, Yong;  Dai, Hui Qi;  Zhu, Guang Zhi; et al.
Favorite | TC[WOS]:17 TC[Scopus]:18  IF:9.5/11.7 | Submit date：2023/01/31
Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer’s disease Journal article
Zhou, Xiao Gang, Qiu, Wen Qiao, Yu, Lu, Pan, Rong, Teng, Jin Feng, Sang, Zhi Pei, Law, Betty Yuen Kwan, Zhao, Ya, Zhang, Li, Yan, Lu, Tang, Yong, Sun, Xiao Lei, Wong, Vincent Kam Wai, Yu, Chong Lin, Wu, Jian Ming, Qin, Da Lian, Wu, An Guo. Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer’s disease[J]. Inflammation and Regeneration, 2022, 42(1).
Authors:  Zhou, Xiao Gang;  Qiu, Wen Qiao;  Yu, Lu;  Pan, Rong;  Teng, Jin Feng; et al.
Favorite | TC[WOS]:28 TC[Scopus]:26  IF:5.0/7.2 | Submit date：2023/01/30
Alzheimer’s Disease  Ampk/ulk1  Autophagy  Nlrp3 Inflammasome  Raf/mek/erk  Thonningianin a  
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Other
2016-01-01
Authors:  Klionsky, Daniel J.;  Abdelmohsen, Kotb;  Abe, Akihisa;  Abedin, Md Joynal;  Abeliovich, Hagai; et al.
Favorite | TC[WOS]:431 TC[Scopus]:24 | Submit date：2022/07/20
Dl-3n-butylphthalide promotes angiogenesis via the extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase/akt-endothelial nitric oxide synthase signaling pathways Journal article
Lu, Xi-lin, Luo, Dan, Yao, Xiao-li, Wang, Guang-lei, Liu, Zhi-yong, Li, Zhen-xing, Li, Wei, Chang, Feng-jun, Wen, Lu, Lee, Simon Ming-yuen, Zhang, Zai-jun, Li, Ling, Zeng, Jin-sheng, Huang, Ru-xun, Pei, Zhong, Ou, Jing-song. Dl-3n-butylphthalide promotes angiogenesis via the extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase/akt-endothelial nitric oxide synthase signaling pathways[J]. Journal of Cardiovascular Pharmacology, 2012, 59(4), 352-362.
Authors:  Lu, Xi-lin;  Luo, Dan;  Yao, Xiao-li;  Wang, Guang-lei;  Liu, Zhi-yong; et al.
Favorite | TC[WOS]:28 TC[Scopus]:31 | Submit date：2018/11/06
Angiogenesis  Dl-3n-butylphthalide  Endothelial Nitric Oxide Synthase  Extracellular Signal-regulated Kinase 1/2  Phosphatidylinositol 3-kinase  Zebrafish